Product Information
- Product Type
- Recombinant Protein
- Expression System
- HEK293
- Domain
- 27-328aa
- UniProt No.
- P17948
- NCBI Accession No.
- NP_002010.2
- Alternative names
- VEGFR1, VEGF R1, VEGFR-1, Vascular endothelial growth factor receptor 1 isoform 1, Fms-like tyrosine kinase 1, FLT-1, FLT1, FLT, FRT, Fms-like tyrosine kinase 1, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular permeability factor receptor, fms-related tyrosine kinase 1, vascular endothelial growth factor, vascularpermeability factor receptor
Product Specification
- Molecular Weight
- 60.3kDa (535aa)
- Concentration
- 0.5mg/ml (determined by absorbance at 280nm)
- Formulation
- Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
- Purity
- > 90% by SDS-PAGE
- Bioactivity
- Measured by its ability to inhibit proliferation using HUVEC human umbilical vein endothelial cells in the presence of Human VEGF165. The ED50 range ≤ 60ng/ml.
- Endotoxin
- < 1 EU per 1ug of protein (determined by LAL method)
- Tag
- hIgG-Tag
- Applications
- SDS-PAGE, Bioactivity
- Storage
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Data
SDS-PAGE
3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain
Biological Activity
Human VEGFR1/Flt-1 inhibit proliferation of the HUVEC human umbilical vein endothelial cells in the presence of Human VEGF165. The ED50 range ≤ 60 ng/ml.
Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.